Mitsuo Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mitsuo Takahashi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Akira Murai
Department of Pharmacology, Faculty of Medicine, Fukuoka University, Japan
1 shared publicationH Kida
The Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido
1 shared publicationH Saikusa
Saikusa Pediatric Clinic, Sasebo
1 shared publicationJuri Fukunaga
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
1 shared publicationM Deguchi
Deguchi Pediatric Clinic, Oomura, Nagasaki
1 shared publicationM Tashiro
Department of Viral Disease and Vaccine Control, National Institute of Infectious Disease, Tokyo and
1 shared publication
Latest Publications
- 20 December 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (14) , 1852-1861
Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains
- 20 December 2007
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (14) , 1852-1861
Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains
- 20 April 2000
- Published by Wiley in Pediatrics International
- Vol. 42 (2) , 204-214
Influenza virus‐induced encephalopathy: Clinicopathologic study of an autopsied case
Background : Rapid progressive encephalopathy with a high fever, consciousness loss and recurrent convulsions has been occasionally reported in children during influenza pandemics in Japan since 1995. We examined a 2‐year old girl with hemorrhagic shock and encephalopathy syndrome associated with acute influenza A virus infection (A/Nagasaki/76/98; H3N2), to answer several questions for which no histologic or virologic data exist. Methods : A clinicopathologic study using immunohistochemical staining and viral genome detection by reverse transcriptase polymerase chain reaction (RT‐PCR) was performed with this autopsied case. Results : The virus antigen was positive in CD8+ T lymphocytes from the lung and spleen. The virus infected a very limited part of the brain, especially Purkinje cells in the cerebellum and many neurons in the pons, without inducing an overt immunologic reaction from the host. The RT‐PCR used for detecting the hemagglutinin gene demonstrated positive bands in all frozen tissues and cerebrospinal fluid taken at autopsy and not in samples obtained on admission. Conclusions : The pathologic change induced by the direct viral invasion cannot be responsible for all of the symptoms, especially for the rapid and severe clinical course of the disease within 24–48 h after the initial respiratory symptoms. Together with the rapid production of several inflammatory cytokines, the breakdown of the blood–brain barrier may induce severe brain edema and can be a major pathologic change for the disease. Any therapeutic strategy to control this multistep progression of the disease could be effective.
- 20 April 2000
- Published by Wiley in Pediatrics International
- Vol. 42 (2) , 204-214
Influenza virus‐induced encephalopathy: Clinicopathologic study of an autopsied case
Background : Rapid progressive encephalopathy with a high fever, consciousness loss and recurrent convulsions has been occasionally reported in children during influenza pandemics in Japan since 1995. We examined a 2‐year old girl with hemorrhagic shock and encephalopathy syndrome associated with acute influenza A virus infection (A/Nagasaki/76/98; H3N2), to answer several questions for which no histologic or virologic data exist. Methods : A clinicopathologic study using immunohistochemical staining and viral genome detection by reverse transcriptase polymerase chain reaction (RT‐PCR) was performed with this autopsied case. Results : The virus antigen was positive in CD8+ T lymphocytes from the lung and spleen. The virus infected a very limited part of the brain, especially Purkinje cells in the cerebellum and many neurons in the pons, without inducing an overt immunologic reaction from the host. The RT‐PCR used for detecting the hemagglutinin gene demonstrated positive bands in all frozen tissues and cerebrospinal fluid taken at autopsy and not in samples obtained on admission. Conclusions : The pathologic change induced by the direct viral invasion cannot be responsible for all of the symptoms, especially for the rapid and severe clinical course of the disease within 24–48 h after the initial respiratory symptoms. Together with the rapid production of several inflammatory cytokines, the breakdown of the blood–brain barrier may induce severe brain edema and can be a major pathologic change for the disease. Any therapeutic strategy to control this multistep progression of the disease could be effective.